Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation recently completed a Phase 2 clinical ...

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation recently updated its clinical study ...

Lebowitz covers the Healthcare sector, focusing on stocks such as Incyte, Alnylam Pharma, and Cogent Biosciences. In addition to Citi, Pliant Therapeutics also received a Hold from Oppenheimer’s Jeff ...

DelveInsight's Uveal Melanoma Market Insights report includes a comprehensive understanding of current treatment practices, ...

Discover the challenges and opportunities for Keros Therapeutics, Inc., including FDA designations, partnerships, and ...

On 19 August 2025, Geron Corporation announced a study is to evaluate the overall survival of participants treated with imetelstat compared to best available therapy with intermediate-2 or high-risk ...

US stocks posted moderate declines on Thursday as underwhelming results from economic bellwether Walmart hit sentiment, while ...

As of 1520 BST, the Dow Jones Industrial Average was down 0.66% at 44,641.85, while the S&P 500 shed 0.39% to 6,370.86 and the Nasdaq Composite came out of the gate 0.27% weaker at 21,114.68.

Today, Governor Matt Meyer announced thirteen new appointments to the Delaware Prosperity Partnership Board following its ...